Dolphin
Senior Member (Voting Rights)
Postorgasmic illness syndrome (POIS) in two patients responding to sertraline: a case report
Thalia Herder, MD ,Rikus Knegtering, MD, PhD ,
Nynke Boonstra, MD, PhD ,
Kor Spoelstra, MD, PhD
The Journal of Sexual Medicine, Volume 23, Issue 4, April 2026, qdag049, https://doi.org/10.1093/jsxmed/qdag049
Published:
11 March 2026
Article history
postorgasmic illness syndrome, sertraline, selective serotonin reuptake inhibitors, ejaculation disorders, case report, sexual health
Issue Section:
Complications and Cases
Collection: ISSM Journals
Postorgasmic illness syndrome (POIS) is characterized by a constellation of flu-like, cognitive, and somatic symptoms that may manifest in both women and men subsequent to orgasm or ejaculation.1 These symptoms can profoundly impair quality of life and sexual functioning, with substantial impact on self-esteem, intimate relationships, and overall psychosocial functioning. Frequently, this leads to avoidance of sexual activity and relational distress.1 The diagnostic criteria most often applied were those proposed by Waldinger et al.2:
- Occurrence of one or more characteristic symptom clusters (general, flu-like, head, eye, nose, throat, or muscle symptoms).
- Symptom onset within a few hours after ejaculation, whether through intercourse, masturbation, or spontaneous emission.
- Symptoms occur consistently or in most ejaculations.
- Symptoms last 2-7 days before spontaneously resolving.
- The symptoms cannot be better explained by another medical condition.
Continues here: